We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Anti-inflammatory Drugs Resurrected To Fight Chronic Pain

Article   Sep 12, 2019 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
Anti-inflammatory Drugs Resurrected To Fight Chronic Pain

Could repurposed drugs bring relief to a dry discovery pipeline?

 
 
 

RELATED ARTICLES

The Future of Neurotechnology: What I’ve Learned As a Gen-Z, Early-stage Founder

Article

In this comment piece, Hubly Surgical CEO Casey Grage gives a perspective on her advancing career, which has seen her go from freshman to startup co-founder in just a few years.

READ MORE

Nanoparticle Drug Delivery Could Offer More Effective Pain Relief Than Opioids

Article

Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.

READ MORE

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Article

In a new study scientists have harnessed advances in proteomics to extensively profile the secretions of senescent cells which are implicated in aging. Their analyses are collated in a database that is now available for researchers in the field.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE